menu search

TransCode Therapeutics Withdraws Public Offering

TransCode Therapeutics Withdraws Public Offering
BOSTON, Oct. 30, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (the “Company”), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that it is withdrawing the underwritten public offering of its common stock. This reflects the Company’s belief that current market conditions were not conducive for an […] The post TransCode Therapeutics Withdraws Public Offering appeared first on ForexTV... Read More
Posted: Oct 30 2023, 20:33
Author Name: forextv
Views: 091921

Search within

Pages Search Results: